Cade Ventures

🌟 Fund Investment! 🌟 We are proud to share Cade’s second investment out of the fund into Akash Systems, a company pioneering the next generation of semiconductors with GaN-on-Diamond technology. Born from the PhD research of co-founder and CEO Felix Ejeckam, Akash Systems' groundbreaking technology is rooted in a simple yet revolutionary idea: using diamond as a thermal conductor in semiconductors. By bringing the hottest part of a transistor within nanometers of synthetic diamond – the most thermally conductive material known to man - Akash has achieved a dramatic reduction in waste heat (a 10x performance improvement for only twice the cost). Akash’s ability to enable more efficient, more powerful cooling is already beginning to impact industries including AI / Deep Tech, Space, EVs, Communications and Clean Energy. Akash Systems is unlocking the next generation of tech innovation, transforming all sectors that Cade Ventures invests in, and we're proud to be a part of their story. See our full blog post here: https://lnkd.in/ewEh3tT5 Learn more about Akash Systems here: www.akashsystems.com -- #VentureCapital #Tech #SemiConductor #Computing #CHIPS #GPUs #GPUCooling #Inventors #Innovation #Investment #Hardware #AI

Hardware is hard. But that’s what makes it a great investment. Despite being more capital-intensive, hardware’s barriers to scale are what make it harder to replicate, creating competitive moats that are increasingly more defensible when combined with intellectual capital and complex software integration. As a result, hardware and pure software startups are just as likely to create fund returning outcomes. As SaaS companies have taken off in recent decades, venture dollars have been increasingly biased against hardware, but they’re missing key nuances: Hardware is the single greatest limitation on software innovation - presenting an opportunity for founders and investors alike. Check out our full blog post here: https://lnkd.in/eJrYqdB2

🌟 Fund Investment! 🌟 Cade Ventures is proud to announce our investment in Function Health, furthering their mission to enable you to live 100 healthy years. We initially backed Function Health in their Seed+ round back in Q1, and we are thrilled to see them secure their Series A, led by Andreessen Horowitz. Cade Ventures’ focus on transforming healthcare through technology is exemplified by Function Health’s innovative co-pilot approach, beginning with continuous, comprehensive lab testing. Their expanding array of actionable tests and data-driven insights empowers individuals to take control of their health. We are excited to back Function Health as they pave the way for a healthier future and honored to be part of such a powerhouse syndicate. See our full blog post here: https://lnkd.in/eKZCqery Learn more about Function Health: www.functionhealth.com #VentureCapital #HealthTech #DigitalHealth #Innovation #CadeVentures #FunctionHealth #Investment #SeriesA #FunctionalHealth #IntegrativeHealth #LabTesting

Our new site is live: www.cadeventure.com If you're building something to transform health or consumer tech and eager to get support from a world-class network of operators, get in touch📬

A few years ago, we at Andreessen Horowitz wrote an article predicting that a consumer health company could become the biggest company in the world. More recently, we’ve argued that building new companies with magical consumer experiences that inspire behavior change is the most powerful way to extend our lifespans. Today, we're thrilled to announce that we’ve led a $53M Series A in Function Health, a company that embodies the vision and excitement we had when writing those theses. The one piece we underestimated is the current state of latent demand among consumers for a new approach to healthcare and longevity. Since launching a beta in 2023, Function has amassed nearly 50k paying members with little marketing. Function aims to integrate all of your health data with all of the world’s health knowledge to best inform what actions you can take to live 100 healthy years. Function helps you fully understand what’s happening in your body, initially through the most powerful data source in healthcare: blood. We couldn’t be more excited to back Mark Hyman, MD, Jonathan Swerdlin, Pranitha Patil, Seth Weisfeld, and Mike Nemke, and to invest alongside Ari Emanuel, Blake Griffin, Jay Shetty, Joel Embiid, Jeff Dean, Matt Damon, Pedro Pascal, Zac Efron, Kevin Hart, Colin Kapernick, Casey Means, MD, Julie Klapstein, Zack Werner, Draft Ventures, G9 Ventures, K5 Ventures, Wisdom VC, 53 Stations, Able Partners, Cade Ventures, Continuum Health Ventures, Fearless Ventures, Pari Passu Venture Partners, Spacecadet, Wisdom Ventures, and so many more. Vijay Pande, PhD, Zach Cohen, Annie Collins, Bryan Kim